Metformin HCL is a biguanide antihyperglycemic agent used for treating non-insulin-dependent diabetes mellitus (NIDDM). It improves glycemic control by decreasing hepatic glucose production, decreasing glucose absorption and increasing insulin mediated glucose uptake. In the present study an attempt has been made to prepare oral dissolving tablets of Metformin HCL which dissolves fast and easy in the oral cavity with enhanced dissolution rate. The tablets were prepared with two superdisintegrants e.g., Croscarmellose sodium, Sodium Starch Glycolate. The blend was examined for Angle of repose, Bulk density, Tapped density, Compressibility index and Hausners ratio. The tablets were evaluated for hardness, friability, disintegration time, diss...
Floating tablet is one of the most suitable dosage forms that used for delivering long term drug rel...
Purpose: To develop and characterize an oral extended-release matrix tablet of metformin hydrochlori...
The aim of present work is to develop a Fast disintegrating solid oral dosage form of Metoprolol suc...
Abstract The aim of the current study is to design a sustained release matrix tablet of metformin HC...
Metformin HCL, the only biguanide still in use today, reduces peripheral insulin resistance and hepa...
The objective of this study is to achieve the controlling dissolution rate of Metformin HCl, a freel...
Shaikh Ershadul Haque, Angappan Sheela Materials Chemistry Division, Centre for Nanomaterials, Scho...
Mucoadhesive tablets is the preferable route of drug delivery due to the ease of administration, pat...
Metformin HCl, a drug from biguanide class, is the most commonly used first-line antihyperglycemic a...
Purpose: To develop and characterize an oral extended-release matrix tablet of metformin hydrochlori...
ABSTRACT Recent advances in novel drug delivery aims to enhance the safety and efficacy of drug mo...
 Objective: The aim of this investigation was to develop and optimize metformin hydrochloride matri...
The present study was aimed at developing, evaluating and optimization of the oral hypoglycaemic dru...
The aim of the present study was to design an oral sustained release matrix tablet of highly water s...
Metformin hydrochloride is a hypoglycemic agent used for the treatment of non-insulin dependent Diab...
Floating tablet is one of the most suitable dosage forms that used for delivering long term drug rel...
Purpose: To develop and characterize an oral extended-release matrix tablet of metformin hydrochlori...
The aim of present work is to develop a Fast disintegrating solid oral dosage form of Metoprolol suc...
Abstract The aim of the current study is to design a sustained release matrix tablet of metformin HC...
Metformin HCL, the only biguanide still in use today, reduces peripheral insulin resistance and hepa...
The objective of this study is to achieve the controlling dissolution rate of Metformin HCl, a freel...
Shaikh Ershadul Haque, Angappan Sheela Materials Chemistry Division, Centre for Nanomaterials, Scho...
Mucoadhesive tablets is the preferable route of drug delivery due to the ease of administration, pat...
Metformin HCl, a drug from biguanide class, is the most commonly used first-line antihyperglycemic a...
Purpose: To develop and characterize an oral extended-release matrix tablet of metformin hydrochlori...
ABSTRACT Recent advances in novel drug delivery aims to enhance the safety and efficacy of drug mo...
 Objective: The aim of this investigation was to develop and optimize metformin hydrochloride matri...
The present study was aimed at developing, evaluating and optimization of the oral hypoglycaemic dru...
The aim of the present study was to design an oral sustained release matrix tablet of highly water s...
Metformin hydrochloride is a hypoglycemic agent used for the treatment of non-insulin dependent Diab...
Floating tablet is one of the most suitable dosage forms that used for delivering long term drug rel...
Purpose: To develop and characterize an oral extended-release matrix tablet of metformin hydrochlori...
The aim of present work is to develop a Fast disintegrating solid oral dosage form of Metoprolol suc...